Issue Brief: Medications for Opioid and Alcohol Use Disorders: Research Insights for Criminal Justice Professionals

Key Takeaways Medications for Substance Use Disorders Are Effective Treatments. Methadone, buprenorphine, and naltrexone are FDA-approved medications for the treatment of opioid use disorder (OUD). Naltrexone, acamprosate, and disulfiram are FDA-approved medications for the treatment of alcohol use disorder (AUD). These medications are effective in reducing substance use and improving recovery outcomes. Patient Choice Matters.…

Read More

Issue Brief: Treating Opioid Use Disorder in Justice-Involved Populations

Download the Issue Brief (PDF) Opioid use disorder (OUD) is a medical condition that is treatable. Individuals involved in the criminal justice system should be screened for OUD. Anyone with moderate to severe OUD should have access to medication treatment for OUD in all criminal justice settings and upon release. OUD is a treatable illness,…

Read More

JJ-TRIALS Resources

NIDA’s Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System (JJ-TRIALS) was a multisite cooperative agreement that launched in 2013 and ended in 2018. JJ-TRIALS was a seven-site cooperative research program designed to identify and test strategies for improving the delivery of evidence-based substance use and HIV prevention and treatment services for…

Read More

New Toolkit Helps Communities Analyze Geospatial Data

The Methodology and Advanced Analytics Resource Center (MAARC) at the University of Chicago (U2CDA050098, Schneider, PI), one of JCOIN’s resource centers, has developed a toolkit that researchers and practitioners can use to explore the spread of opioid or other drug use within social and spatial networks. The Opioid Environment Toolkit provides an introduction to geographic…

Read More